Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Options, New, 2023 Q3, Page 5

CITADEL ADVISORS LLC historic quarter change: USA Options, New

In put and call options, at their filed underlying value (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 48,961 positions, added to 115,287, reduced 112,564 and sold out of 46,247.

  • Q3 2023: Stock BELLEROPHON THERAPEUTICS INC; Country of operation —; Class COM NEW · Call; Shares before 0.
  • Q3 2023: Stock NN; Country of operation United States; Class COMMON STOCK · Put; Shares before 0.
  • Q3 2023: Stock LNSR; Country of operation United States; Class COM · Put; Shares before 0.
  • Q3 2023: Stock STTK; Country of operation United States; Class COM · Put; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2023BELLEROPHON THERAPEUTICS INC
CUSIP 078771300
—COM NEW · Call02,600+2,600$0$1,040+$1,0402023-11-14
Q3 2023NN
NEXTNAV INC
United StatesCOMMON STOCK · Put0200+200$0$1,028+$1,0282023-11-14
Q3 2023LNSR
LENSAR INC
United StatesCOM · Put0300+300$0$927+$9272023-11-14
Q3 2023STTK
SHATTUCK LABS INC
United StatesCOM · Put0500+500$0$760+$7602023-11-14
Q3 2023ORION ENERGY SYS INC
CUSIP 686275108
—COM · Call0600+600$0$756+$7562023-11-14
Q3 2023UPHEALTH INC
CUSIP 91532B200
—COM NEW · Put0750+750$0$735+$7352023-11-14
Q3 2023VBI VACCINES INC CDA
CUSIP 91822J202
—COM NEW · Put01,100+1,100$0$733+$7332023-11-14
Q3 2023180 LIFE SCIENCES CORP
CUSIP 68236V203
—COM NEW · Call01,145+1,145$0$689+$6892023-11-14
Q3 2023SYRE
AEGLEA BIOTHERAPEUTICS INC
United StatesCOM NEW · Call056+56$0$686+$6862023-11-14
Q3 2023NANOVIRICIDES INC
CUSIP 630087302
United StatesCOM · Put0500+500$0$670+$6702023-11-14
Q3 2023USD PARTNERS LP
CUSIP 903318103
—COM UT REP LTD · Call01,100+1,100$0$660+$6602023-11-14
Q3 2023CATALYST BIOSCIENCES INC
CUSIP 14888D208
—COM NEW · Call01,100+1,100$0$531+$5312023-11-14
Q3 2023MILESTONE SCIENTIFIC INC
CUSIP 59935P209
United StatesCOM NEW · Put0500+500$0$460+$4602023-11-14
Q3 2023NEUROONE MED TECHNOLOGIES CO
CUSIP 64130M209
United StatesCOM NEW · Put0500+500$0$445+$4452023-11-14
Q3 2023AIRG
AIRGAIN INC
United StatesCOM · Call0100+100$0$367+$3672023-11-14
Q3 2023THE BEACHBODY COMPANY INC
CUSIP 073463101
—COM CL A · Put01,200+1,200$0$354+$3542023-11-14
Q3 2023NUBURU INC
CUSIP 67021W103
—COMMON STOCK · Call01,000+1,000$0$348+$3482023-11-14
Q3 2023ADVERUM BIOTECHNOLOGIES INC
CUSIP 00773U108
—COM · Put0200+200$0$300+$3002023-11-14
Q3 2023LAB
STANDARD BIOTOOLS INC
United StatesCOM · Put0100+100$0$290+$2902023-11-14
Q3 2023NUVB
NUVATION BIO INC
United StatesCOM CL A · Put0200+200$0$268+$2682023-11-14
Q3 2023IRIDEX CORP
CUSIP 462684101
United StatesCOM · Call0100+100$0$254+$2542023-11-14
Q3 2023KULR TECHNOLOGY GROUP INC
CUSIP 50125G109
—COM · Put0700+700$0$251+$2512023-11-14
Q3 2023ARCA BIOPHARMA INC
CUSIP 00211Y506
—COM · Put0100+100$0$201+$2012023-11-14
Q3 2023MIND C T I LTD
CUSIP M70240102
—ORD · Put0100+100$0$187+$1872023-11-14
Q3 2023ASTRA SPACE INC
CUSIP 04634X202
—CL A NEW · Put0100+100$0$185+$1852023-11-14
Q3 2023SKILLSOFT CORP
CUSIP 83066P200
—CL A · Put0200+200$0$177+$1772023-11-14
Q3 2023CHICKEN SOUP FOR THE SOUL EN
CUSIP 16842Q100
—CL A · Put0500+500$0$173+$1732023-11-14
Q3 2023ENGLOBAL CORP
CUSIP 293306106
—COM · Call0500+500$0$169+$1692023-11-14
Q3 2023REAX
THE REAL BROKERAGE INC
United StatesCOM NEW · Put0100+100$0$145+$1452023-11-14
Q3 2023AVAH
AVEANNA HEALTHCARE HLDGS INC
United StatesCOM · Call0100+100$0$119+$1192023-11-14
Q3 2023BETTER THERAPEUTICS INC
CUSIP 08773T104
—COMMON STOCK · Put0300+300$0$116+$1162023-11-14
Q3 2023180 LIFE SCIENCES CORP
CUSIP 68236V203
—COM NEW · Put0180+180$0$108+$1082023-11-14
Q3 2023TERRAN ORBITAL CORPORATION
CUSIP 88105P103
—COM · Call0100+100$0$83+$832023-11-14
Q3 2023ENTERA BIO LTD
CUSIP M40527109
—SHS · Put0100+100$0$73+$732023-11-14
Q3 2023SYRE
AEGLEA BIOTHERAPEUTICS INC
United StatesCOM NEW · Put04+4$0$49+$492023-11-14
Q3 2023A K A BRANDS HLDG CORP
CUSIP 00152K101
—COM · Put0100+100$0$43+$432023-11-14
Q3 2023GOLD RESOURCE CORP
CUSIP 38068T105
United StatesCOM · Put0100+100$0$43+$432023-11-14
Q3 2023ENSERVCO CORP
CUSIP 29358Y201
—COM NEW · Put0100+100$0$38+$382023-11-14
Q3 2023GALMED PHARMACEUTICALS LTD
CUSIP M47238122
—SHS NEW · Call042+42$0$26+$262023-11-14

Similar Firms

Firm NameCountry13F ValueHoldings
Capital Research Global InvestorsUnited States$644.560B459
Invesco Ltd.United States$653.294B23,552
CHARLES SCHWAB INVESTMENT MANAGEMENT INCUnited States$654.473B3,645
UBS Group AGSwitzerland$666.317B22,771
ROYAL BANK OF CANADACanada$570.144B25,608
Bank of New York Mellon CorpUnited States$543.906B33,728
WELLINGTON MANAGEMENT GROUP LLPUnited States$535.463B7,458
WELLS FARGO & COMPANY/MNUnited States$530.336B17,971
Capital World InvestorsUnited States$732.940B620
DIMENSIONAL FUND ADVISORS LPUnited States$481.393B13,635